Member Info for Kendall12

So how many procedures are currently performed by robots in the Spire Hospitals ?

How embedded is AI across, X-Rays, drug prescription, patient diagnosics, administative functions currently in the Spire Clinics and hospitals?

Thanks for the benefit of your knowledge on chip makers - I had no idea that all roads led to them.

As for software - you were doing so well until you gave the game away. Software will likely be obsolete within 5 years and less than that if you believe Elon Musk.

Could not agree less Bigdaddypump - Healthcare is an industry set for explosive transformation on the back of AI, drug development and Robotics for example.

Robots will be able perform routine procedures and are already so . AI is already being used to analse X-Rays and in patholgy. It will also hugely improve admin effeciency. Can you imagine teh thruput that will be achieved and at a fraction of today's cost.

The likes of Mediclinic will be fully aware of the embedded potential within SPI and hence they will not lie down with their legs in the air - and quite rightly so.

SPI suffers from a very small float and a few large shareholders that can only exit via a liquidity event.

The Real Estate Value is not quite that straightforward - re-purposing hospitals, putting aside potential government interference would be very difficult and expensive.

Repacement cost is way above mkt value so would be most attractive for an existing industry participant.

Alanstatener - ignore the village idiot, he is rude to everyone without exception. Its particularly severe as the day wears on and his meds start to lose tehir effectiveness.

You are of course absolutely right to highlight this. I was in China earlier this year and Robots are already performing routine minor procedures. Robotics is seen by many as the future and the UK is one of the world leaders in this field. This along with AI will be absolutely transformational for this sector.

"I would say the Remgro deal makes a Mediclinic bid for the remaining 70% less likely, if it ever was on the cards."

I think my post is clear and it is not as represented by you, yet again.

Still waiting for the list of PE deals with hospitals involving NHS ?

Isn't the whole point of the strategic review that the major shareholders all value their stakes at a price higher than the current market value?

Another really dumb comment but on a Friday night and drinks time always very receptive to a good old belly laugh. Everyone is a seller at the right price - eeeeer

Perhaps you would like to be specific about the misinformation that you claim I have posted. I have provided sources for others, not you..

Perhaps you would also now like to name the many PE deals involving hospitals and the NHS that tou referred to earleir. You seem to to have a very selective self-serving inventive memory issue in addition to your anger anxiety issues. You might even be able to get a 2 for 1 med deal for both conditions - I would try a super strong laxative - it will relieve all manner of constipations.

Mediclinic will value their stake however they please and will pay scant disregard to water carriers such as you - thats their prerogative and holding 30% of a company is a tad different to your position which I suspect would give us the biggest belly laugh of all time should it ever be revealed.

I should just add that if I were a betting man Bigdaddyypump I would say the Remgro deal makes a Mediclinic bid for the remaining 70% less likely, if it ever was on the cards.

I think Medeclinic still value their share in Spire to be well in excess of £3 , maybe even £3.40 and will only consider diversting at those levels. I think they will sit tight to realise this value, one way or another, as in the meantime it remains a very valuable strategic asset - they also don't seem to be under any pressure to sell.

For the time being Remgro & IHL seem to view Spire Uk as a valuable strategic asset, each retaining their ownership shares. It was also excluded from the recent restructuring.

Some will view this as pointing to an increased likelihood of a bid for the remaining 70% and others the exact opposite. I don't know what Johaan Ruperts long term plan is but clearly diversifying further into the UK market might be a consideration.

I guess we will have to wait until the AGM for an update on the strategic review.

Whilst you are overly exercised by the price paid by Mediclinic for its stake in SPI, as is evidnced by your repititive posts of the same point.

For Mediclinic it is totally irrelevant, their focus is solely upon extracting the value they believe lies within SPI whether it be via a liquidity event or operational changes. I am not privy to what Medeclinic believe to be fair value but the best available steers point to a number north of £3 - that is indisputable. Whether it arrisve is another matter and nobody knows if it will or not.

In the meantime I remain a committed buyer and long term holder.

PE deals (plural) with Hospitals providing NHS services - still waiting ?

Sorry to have to break it to you but your view does not carry any weight- the only view that counts here is that of Mediclinic and I think its pretty clear from all the anecdotal eveidence that they will get out of bed for less than £3 and thats the bottom line, like it or not.

You are clearly in denial - the FT article clearly states that SPI was bring pressured to put itself up for sale for at least £3.40 per share - what don't you understand about that ? Its per share - is what they pay each and every shareholder - net debt is assumed by the acquirer in addition to the payment per per share to each and every shareholder.

My post below is a verbatim extract from the FT article for those that are unable to pull up the article from the link.

Its se

For those who cannot acces the FT - I have posted the article below - dated 18th Sept 2025.

https://www.ft.com/content/e91676aa-98ed-4c06-8063-4b8f5cdc632f?utm_source=chatgpt.com&syn-25a6b1a6=1

Spire Healthcare Group has tapped bankers at Rothschild to advise on a potential sale following pressure from shareholders in a deal that could value the UK’s largest private hospital company at more than £1.4bn.

Top investors, including hedge fund Toscafund and investment manager Harwood Capital — along with its activist trust Achilles — are urging London-listed Spire to put itself up for sale for at least £3.40 a share, said people familiar with the situation.

Some shareholders want Spire to explore a takeover given that its share price has languished since 2021, when it rejected a proposed £2.50-a-share takeover bid by Australia-listed Ramsay Healthcare. Shareholders, including Toscafund, said at the time that the proposed deal undervalued the business.

Spire runs 38 hospitals and more than 50 clinics, medical centres and consulting rooms across the UK for private and NHS patients. It also operates a network of private GPs and provides occupational health services to more than 800 corporate clients.

Spire has been benefiting from long NHS waiting lists, which has driven an increase in the number of people turning to private healthcare. It has also expanded its partnership with the health service, which accounts for more than 30 per cent of revenues. The NHS agrees annual settlements with the company for the cost of care, and prices increased 3.9 per cent in 2024.

Just so everyone is aware and has been previously reported by many , Kyn2 & UkStock are one and the same. I don't think anymore needs to be said.

Lastly we are all waiting for the details of the multiple deals previously closed between Hospitals & PE with Government involvement.

https://www.ft.com/content/e91676aa-98ed-4c06-8063-4b8f5cdc632f?utm_source=chatgpt.com&syn-25a6b1a6=1

You really should look a bit harder - there was also a segment on City A.M. which talked about a £3.40 number.

Thats it for me folks .

Some corrections - does you arrogance know no bounds.

I will respond to your self serving rude nonsense such as a quoting me as saying Toscafund and Mediclinic "demanding" £3 per share. for the benefit of others, not you. I would also suggest you read my post again and a little more closely this time. Anything for a bit of effect. "demanding" - you must be a journo at the local failing rag.

The Financial Times reported £3.40 and this was picked up by other outlets. It was a very widely banded about number as the minimum required bid to get the major shareholoders on board. Sky reported a £1.5 m bid ( which is normally the quoted figure for 100% of the share capital, not less debt plus cash or any other adjustments). You can work the maths on that one.

Your old chum Chris Mills is on record as saying that major shareholders will have to adjust their expectations for £3.25 to £3. No doubt he watered down those numbers to suit his own book as he always does.

Ramsey bid of £2.50 was rejected some 5 years ago, compound £2.50 at a rate of interest of your choice.

Bridgepoints muted bid of £2.30 was so far off the money that they walked knowing it would be laughed out of court nothwithstanding any potential for any further negogiation after the PUSU.

It does not take a rocket scientist to work out that anything short of £3 is a waste of everyones time.

You don't need to launch a sales process to sell a company- potential suitors simply notify the Board of an intention to make an offer to acquire 100% of issued share capital. That can happen at any time. The Board only started a formal sales process as part of the strategic review after succumbing to pressure from activist shareholders. ToscaFund and Mediclinic have remained very tight-lipped on the whole matter.

With high waiting lists , cost of living crisis and a generally failing NHS service a PE asset strip of the countries largest private health company is not a look the Government would welcome. PE also has extensive interests in companies with Government connections, and indeed Government contracts, surely you are not so naive to believe the Governement would not bring pressure to bear. I am aware of the hospital deal that you are most likely referring to and the circumstances were very different and it was small by compariosn and did not involve an outright sale. Perhaps you would like to let everyone know the hospitals deals (plural) involving PE and the Government ?????????? I wait with baited breathe.

I am all for the major shareholders fighting for the value they believe lies within SPI and not rolling over with their legs in the air to fit the agenda of a bunch of retail investors that have taken a punt on a takeover and a quick turn.

I am more than happy to buy and hold, for many years if necessary, value is always realised in time. If a bid comes in at £3 + then happy days.

You are very quick to bully others whilst providing nothing of substan

"No one will offer a 70-80% premium" - if true, then there will be no deal.

It has been made abundantly clear that Mediclinic and Toscafunds funds expectations begin with a 3. Even Harwood expect a premium in excess of 80% to todays price which quite honestly is a complete red herring anyway.

There is absolutely no incentive whatsover for them to sell at below broker consensus 12 month price expectations.

Unfortunately those that have bought for a quick turn on a takeover have been badly burnt and are now seeing things through one way glasses.

This remains a great opportunity to buy a cheap stock as I for one continue to do, it includes a zero takeover premium and the company has excellent growth potential and all backed by bricks and mortar.

The Board have done a decent enough job, (financial metrics are as good as all in the sector om most counts). The Board cannot control the share price. Everyone on here claims the stock to be worth far more than the market is recognising, so who's fault is that?

If a takeover remains a posssibility the numbers will be >£3.25 hence the extended offer period most likeley due to multiple interested parties for what is potentially very complex deal including possivble Govt intervention. Not sure the lefty Labour lot will take kindly to a PE asset strip (SLB) of hospitals servicing the public sector.

Otherwise we will be greeted with an announcement at the AGM that despite the Boards best efforts a buyer has not been found and this will be softened by a bunch of costs reduction, revenue enhancement iniatives and possibly a tie up with a company(s) to drive further business growth.

"No one will offer a 70-80% premium" - if true, then there will be no deal.

It has been made abundantly clear that Mediclinic and Toscafunds funds expectations begin with a 3. Even Harwood expect a premium in excess of 80% to todays price which quite honestly is a complete red herring anyway.

There is absolutely no incentive whatsover for them to sell at below broker consensus 12 month price expectations.

Unfortunately those that have bought for a quick turn on a takeover have been badly burnt and are now seeing things through one way glasses.

This remains a great opportunity to buy a cheap stock as I for one continue to do, it includes a zero takeover premium and the company has excellent growth potential and all backed by bricks and mortar.

The Board have done a decent enough job, (financial metrics are as good as all in the sector om most counts). The Board cannot control the share price. Everyone on here claims the stock to be worth far more than the market is recognising, so who's fault is that?

If a takeover remains a posssibility the numbers will be >£3.25 hence the extended offer period most likeley due to multiple interested parties for what is potentially very complex deal including possivble Govt intervention. Not sure the lefty Labour lot will take kindly to a PE asset strip (SLB) of hospitals servicing the public sector.

Otherwise we will be greeted with an announcement at the AGM that despite the Boards best efforts a buyer has not been found and this will be softened by a bunch of costs reduction, revenue enhancement iniatives and possibly a tie up with a company(s) to drive further business growth.

Your reply was as expected and I will never understand why you take such personal delight in mocking others. Their intentions are fine but their knowledge of the industry does not match yours so it is inevtiable that they may get things wrong, but I dont see any reason to mock people for that.

I was rather hoping that your industry experience night be used in a positive way to put Mr. Gibson under the spotlight for his incompetence , whilst I also acknowledge this maybe far too late as far as a turnaround is concerned.

UKstock and his alter Ego Kjn2 have been royally rumbled by all. If I were it/them, I retreat with my tail firmly between my legs in embarrasment of dupliticous and dis-ingenous self serving posts.

UKStock even suggested that Harwood and ToscaFund should buy more shares and yes you guessed it KjN2 posted in support of this to reduce its average.

The sad thing about this is that "they//it" take us all as being fools dumber than him, he has an arrogance and rudeness which surely only an upping daily dosage has any possible chance of rectifying.

Let me put you and UKStock out of your misery and address your curiosity and then hopefully you will desist from your endless repetitive posting of the same message.

Major shareholders will do absolutely nothing whatsoever to remove the Board. They have had amle opportunity to do this for many years and have chossen not to so. Harwood, one of the main activists are ven on rtecord as having expressed its satisfaction with the current CEO and management team.

Compounding past share offers at fairly conservative rates of interest would value the shares at circa £5 today so they have only themselves to blame. If the Board were to be sacked or not re-elected en masse the share price would tank unless Houndini had been lined up to replace them.

Try owning your own investment decisions rather than continually blaming others and advancing the most ludicrous suggestions such as why arn't Harwood & ToscaFund buying more, main shareholders doing a MBO and £2.50 a share is an easy deal for PE.

I trust that ends your curiousity but if not , maybe you will not have long to wait, always better than throwing your toys out the pram.

Kyn2 & UkStock - another one of the dumbest posts ever. Harwood began buying at £1.20 and why would Tosca buy stock to marginally reduce their average price at best without any certainty of a liquidity event. Tosca are looking to exit not add - is that too difficult a situtaion for you to understand or is proposing that they both buy more just a self serving comment driven by your own personal position. Perhaps you should ask them why they are not adding and give us all another belly laugh.